| Literature DB >> 34886385 |
Paula Costa-Urrutia1, Valentina Colistro2, Valentina Franco-Trecu3, Julio Granados4, Rafael Álvarez Fariña5, Martha Eunice Rodríguez-Arellano1.
Abstract
The aim of this study was to assess lipid disorders in children from five ethnic groups, both urban and indigenous, from northern and central Mexico. We measured the lipid profile to determine the ability of the body mass index (BMI) to discriminate an abnormally high lipid level using receiving operating characteristics (ROC). We analyzed the association and interaction of obesity and ethnicity with lipid disorders using generalized linear models in 977 children. The highest prevalence of lipid disorders (high TG, high TC, high LDL, high APOB, and dyslipidemia) was found in central Mexico-Mexico City and urban northern Mexico. The BMI performed better at predicting low HDL in Seris, a northern indigenous group (0.95, CI: 0.69-0.85), and Mexico City (0.75, CI: 0.69-0.82), and high LDL in Puebla (central Mexico, 0.80, CI: 0.69-0.85). Obesity significantly (p < 0.05) increases lipid disorders by around two times (OR~2) for almost all lipid markers. Obesity and ethnic interaction increase the lipid disorders by more than five times for different lipid markers and ethnic groups (high total cholesterol OR = 5.31; low HDL OR = 5.11, and dyslipidemia OR = 5.68). Lipid disorders are not restricted to children with high BMIs, but obesity exacerbates these. The emerging lipid disorder risk depends on the ethnic group.Entities:
Keywords: Mexican; children; dyslipidemias obesity; ethnicity; lipid
Mesh:
Substances:
Year: 2021 PMID: 34886385 PMCID: PMC8656470 DOI: 10.3390/ijerph182312659
Source DB: PubMed Journal: Int J Environ Res Public Health ISSN: 1660-4601 Impact factor: 3.390
Demographic, anthropometric, and lipid profiles of schoolchildren from northern (NM) and central Mexico (CM) for the overall sample and by ethnic group.
| Boys, | Girls, | ||||
|---|---|---|---|---|---|
| All, | Median | IQR | Median | IQR |
|
| Age | 9.0 | 4.0 | 9.0 | 3.0 | 0.29 |
| BMI | 17.6 | 6.7 | 17.0 | 4.6 | 0.01 |
| BMIz | −0.3 | 1.4 | −0.2 | 1.1 | 0.60 |
| TG | 87.0 | 61.9 | 85.5 | 51.0 | 0.91 |
| TC | 157.8 | 44.5 | 155.0 | 38.0 | 0.10 |
| HDL | 56.5 | 15.4 | 55.1 | 17.3 | 0.27 |
| LDL | 83.5 | 30.6 | 81.1 | 26.0 | 0.20 |
| ApoA1 | 153.0 | 52.0 | 153.0 | 58.0 | 0.23 |
| ApoB | 86.0 | 34.6 | 87.5 | 27.8 | 0.38 |
| CM-Mexico City, | |||||
| Age | 9.0 | 4.0 | 9.0 | 4.0 | 0.42 |
| BMI | 20.4 | 8.3 | 18.5 | 5.4 | 0.02 |
| BMIz | 0.3 | 1.7 | 0.3 | 1.3 | 0.75 |
| TG | 102.0 | 75.0 | 102.0 | 52.5 | 0.71 |
| TC | 173.0 | 46.0 | 169.5 | 35.5 | 0.05 |
| HDL | 56.1 | 16.1 | 57.2 | 20.2 | 0.91 |
| LDL | 92.8 | 37.9 | 89.6 | 28.1 | 0.09 |
| ApoA1 | 152.0 | 42.0 | 142.0 | 34.3 | 0.01 |
| ApoB | 82.0 | 29.0 | 82.0 | 25.5 | 0.94 |
| CM-Puebla, | |||||
| Age | 9.0 | 3.0 | 9.0 | 3.0 | 0.52 |
| BMI | 16.6 | 3.4 | 16.7 | 3.5 | 0.86 |
| BMIz | 0.5 | 0.8 | 0.3 | 0.8 | 0.02 |
| TG | 77.1 | 47.7 | 81.8 | 46.5 | 0.19 |
| TC | 145.3 | 31.4 | 141.5 | 32.5 | 0.82 |
| HDL | 54.8 | 15.4 | 49.7 | 14.3 | 0.01 |
| LDL | 79.8 | 19.2 | 79.5 | 27.0 | 0.21 |
| NM-Urban, | |||||
| Age | 8.0 | 3.0 | 9.0 | 3.0 | 0.47 |
| BMI | 18.3 | 6.1 | 17.9 | 6.6 | 0.48 |
| BMIz | 01.0 | 1.3 | 01.0 | 1.4 | 0.47 |
| TG | 89.0 | 59.5 | 89.5 | 71.0 | 0.80 |
| TC | 167.0 | 48.0 | 170.5 | 37.0 | 0.61 |
| HDL | 63.6 | 16.6 | 67.4 | 16.3 | 0.38 |
| LDL | 84.0 | 33.3 | 85.4 | 25.1 | 0.97 |
| ApoA1 | 194.0 | 31.5 | 191.0 | 44.3 | 0.59 |
| ApoB | 100.3 | 21.9 | 94.0 | 21.8 | 0.15 |
| NM-Yaquis, | |||||
| Age | 9.0 | 4.0 | 9.0 | 5.0 | 0.57 |
| BMI | 16.2 | 4.1 | 16.2 | 4.0 | 0.86 |
| BMIz | −0.6 | 0.9 | −0.4 | 0.9 | 0.50 |
| TG | 79.0 | 51.5 | 88.0 | 38.0 | 0.13 |
| TC | 145.5 | 32.0 | 151.0 | 28.0 | 0.16 |
| HDL | 55.7 | 11.9 | 52.7 | 11.1 | 0.24 |
| LDL | 72.4 | 17.5 | 77.1 | 18.1 | 0.06 |
| ApoA1 | 139.5 | 29.3 | 135.0 | 22.0 | 0.14 |
| ApoB | 68.5 | 21.4 | 74.0 | 14.0 | 0.07 |
| NM-Seris, | |||||
| Age | 9.5 | 3.0 | 10.0 | 2.3 | 0.72 |
| BMI | 17.6 | 4.0 | 17.3 | 4.0 | 0.89 |
| BMIz | −0.5 | 0.8 | −0.4 | 1.0 | 0.75 |
| TG | 77.0 | 44.0 | 73.0 | 21.8 | 0.71 |
| TC | 152.0 | 36.3 | 148.0 | 29.3 | 0.56 |
| HDL | 54.5 | 6.3 | 54.4 | 9.0 | 0.81 |
| LDL | 68.3 | 21.7 | 72.3 | 15.6 | 0.32 |
| ApoA1 | 145.0 | 19.0 | 139.0 | 28.3 | 0.35 |
| ApoB | 65.0 | 24.6 | 67.5 | 14.8 | 0.40 |
Interquartile range (IQR) and p-value (p) from Mann-Whitney U test gender pairwise comparisons. Body mass index (BMI), BMI z-score (BMIz), triglycerides (TG, mg/dL), total cholesterol (TC, mg/dL), high density lipoprotein (HDL in mg/dL), low density lipoprotein (LDL in mg/dL), apolipoprotein A1, (ApoaA, mg/dL), apolipoprotein B, (ApoB mg/dL).
Prevalence of lipid disorders among schoolchildren in central and northern Mexico for the overall sample (All) by ethnic group and by obesity (OB).
| Prevalence | All | CM-Mexico City | CM-Puebla | NM-Urban | NM-Yaquis | NM-Seris |
|---|---|---|---|---|---|---|
| OB % | 17 | 28.6 | 6.3 | 23.6 | 8.14 | 20.4 |
| High TG, | 496 (50.7) | 198 (60.9) | 138 (45.7) | 86 (58.1) | 51 (37.8) | 23 (34.3) |
| % High TG with OB | 23.0 | 34.8 | 10.9 | 24.4 | 17.4 | 21.7 |
| High TC, | 339 (34.7) | 176 (54.2) | 45 (14.9) | 76 (51.4) | 26 (19.3) | 16 (23.9) |
| % High TC with OB | 23.6 | 30.1 | 8.9 | 18.4 | 23.1 | 18.8 |
| Low HDL, | 166 (17.0) | 58 (17.8) | 83 (27.5) | 5 (3.4) | 15 (11.1) | 5 (7.5) |
| % Low HDL with OB | 28.3 | 56.9 | 13.3 | 0.0 | 0 | 60.0 |
| High LDL | 132 (13.5) | 84 (25.4) | 22 (7.3) | 20 (13.5) | 4 (3.0) | 2 (3.0) |
| % High LDL with OB | 28.0 | 33.3 | 18.2 | 25.0 | 0 | 0 |
| Low ApoA1, | 58 (8.6) | 27 (8.3) | na | 2 (1.4) | 24 (17.8) | 5 (7.4) |
| % Low ApoA1 with OB | 20.7 | 33.3 | na | 0.0 | 4.1 | 40.0 |
| High ApoB, | 242 (35.8) | 118 (36.3) | na | 93 (62.8) | 22 (16.3) | 9 (13.4) |
| % High ApoB with OB | 31.0 | 37.3 | na | 24.7 | 27.3 | 22.2 |
| Dyslipidemia, | 644 (66.0) | 255 (75.5) | 175 (58.0) | 113 (76.4) | 70 (52.0) | 31 (46.3) |
| % Dyslipidemia with OB | 21.7 | 32.2 | 10.3 | 22.1 | 12.9 | 19.4 |
Lipid disorders (high or low levels) were classified according to the borderline-high criteria of the Expert Panel on Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents of the National Heart, Lung and Blood Institute. na, information for ApoaA and ApoB in CM-Puebla is not available.
The ability of body mass index to discriminate lipid disorders. Areas under the ROC curve (AUCs), 95% confidence intervals (CI), and p-values (p) of the body mass index for cardiometabolic risk in Mexican children, for the overall (All) sample and by ethnic group.
| AUC (95%CI), | ||||||
|---|---|---|---|---|---|---|
| All | CM-Mexico City | CM-Puebla | NM-Urban | NM-Yaquis | NM-Seris | |
| High TG | 0.68 (0.65–0.71), <0.001 | 0.68 (0.62–0.74), <0.001 | 0.67 (0.60–0.73), <0.001 | 0.55 (0.45–0.64), 0.322 | 0.66 (0.56–0.76), 0.002 | 0.82 (0.73–0.93), <0.001 |
| High TC | 0.60 (0.56–0.66), <0.001 | 0.54 (0.48–0.61), 0.183 | 0.57 (0.47–0.66), 0.144 | 0.47 (0.37–0.56), 0.464 | 0.53 (0.39–0.67), 0.652 | 0.62 (0.46–0.79), 0.146 |
| Low HDL | 0.64 (0.59–0.69), <0.001 | 0.75 (0.69–0.82), <0.001 | 0.66 (0.60–0.73), <0.001 | 0.46 (0.28–0.65), 0.700 | 0.50 (0.26–0.60), 0.411 | 0.95 (0.90–1.00), <0.001 |
| High LDL | 0.61 (0.56–0.69), <0.001 | 0.59 (0.52–0.66), 0.010 | 0.80 (0.69–0.85), <0.001 | 0.50 (0.37–0.64), 0.964 | 0.50 (0.16–0.64), 0.412 | 0.67 (0.30–1.00), 0.352 |
| Low ApoA1 | 0.50 (0.40–0.56), 0.562 | 0.56 (0.42–0.67), 0.233 | na | 0.53 (0.32–0.73), 0.782 | 0.50 (0.33–0.58), 0.585 | 0.74 (0.47–1.00), 0.081 |
| High ApoB | 0.64 (0.60–0.68), <0.001 | 0.60 (0.53–0.62), 0.003 | na | 0.60 (0.50–0.69), 0.063 | 0.68 (0.54–0.81), 0.012 | 0.77 (0.61–0.94), 0.001 |
| Dyslipidemia | 0.68 (0.64–0.71), <0.001 | 0.68 (0.61–0.76), <0.001 | 0.64 (0.58–0.70), <0.001 | 0.53 (0.41–0.65), 0.141 | 0.57 (0.48–0.67), 0.146 | 0.76 (0.64–0.87), <0.001 |
Lipid disorders (high or low levels) were classified were according to the borderline-high criteria of the Expert Panel on Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents of the National Heart, Lung and Blood Institute. na, information for ApoA1 and ApoB in CM-Puebla is not available.
Lipid disorder association analysis with obesity (OB) of central and northern Mexican schoolchildren from five ethnic groups, providing the estimate, standard error (SE), Z-statistic (Z) odds ratio, 95% confidence interval (CI 95%), and p-value (p).
| High TG | Estimate | SE | Z | OR (CI 95%) |
|
|---|---|---|---|---|---|
| Intercept | −0.95 | 0.32 | −2.99 | 0.39 (0.21, 0.72) | 0.003 |
| Age | 0.13 | 0.03 | 3.93 | 1.14 (1.07, 1.21) | ˂0.001 |
| OB | 0.9 | 0.19 | 4.61 | 2.45 (1.68, 3.62) | ˂0.001 |
| NM-Urban | 0.01 | 0.21 | 0.05 | 1.01 (0.67, 1.52) | 0.960 |
| CM-Puebla | −0.39 | 0.17 | −2.33 | 0.67 (0.48, 0.94) | 0.020 |
| NM-Seris | −1.04 | 0.29 | −3.6 | 0.36 (0.20, 0.62) | ˂0.001 |
| NM-Yaquis | −0.76 | 0.22 | −3.48 | 0.47 (0.32, 0.72) | ˂0.001 |
| High TC | |||||
| Intercept | 0.12 | 0.13 | 0.92 | 1.13 (0.87, 1.46) | 0.360 |
| OB | 0.16 | 0.25 | 0.65 | 1.17 (0.72, 1.91) | 0.520 |
| NM | 0.07 | 0.23 | 0.32 | 1.08 (0.69, 1.70) | 0.750 |
| CM-Puebla | −1.90 | 0.21 | −8.86 | 0.15 (0.10, 0.23) | <0.001 |
| NM-Seris | −1.41 | 0.34 | −4.14 | 0.25 (0.12, 0.46) | <0.001 |
| NM-Yaquis | −1.77 | 0.28 | −6.38 | 0.17 (0.11, 0.29) | <0.001 |
| NM*OB | −0.76 | 0.46 | −1.64 | 0.47 (0.19, 1.15) | 0.100 |
| CM-Puebla*OB | 0.29 | 0.64 | 0.46 | 1.34 (0.34, 4.36) | 0.650 |
| NM-Seris*OB | 0.84 | 0.86 | 0.97 | 2.31 (0.39, 12.64) | 0.330 |
| NM-Yaquis*OB | 1.67 | 0.70 | 2.39 | 5.31 (1.35, 21.81) | 0.021 |
| Low HDL | |||||
| Intercept | −3.08 | 0.49 | −6.31 | 0.05 (0.02, 0.12) | <0.001 |
| Age | 0.09 | 0.05 | 1.94 | 1.09 (1.00, 1.20) | 0.051 |
| OB | 1.56 | 0.31 | 5.09 | 4.74 (2.62, 8.72) | <0.001 |
| Gender (girls) | 0.47 | 0.19 | 2.49 | 1.60 (1.11, 2.31) | 0.011 |
| NM-Urban | −1.03 | 0.51 | −2.02 | 0.36 (0.12, 0.92) | 0.043 |
| CM-Puebla | 1.00 | 0.26 | 3.88 | 2.72 (1.66, 4.57) | <0.001 |
| NM-Seris | −1.46 | 0.75 | −1.94 | 0.23 (0.04, 0.82) | 0.052 |
| NM-Yaquis | 0.11 | 0.35 | 0.31 | 1.11 (0.55, 2.19) | 0.763 |
| NM-Urban*OB | −16.07 | 64.21 | −0.02 | 0.01 (0.01, 61.55) | 0.982 |
| CM-Puebla*OB | −0.18 | 0.58 | −0.32 | 0.83 (0.27, 2.64) | 0.752 |
| NM-Seris*OB | 1.63 | 1.10 | 1.48 | 5.11 (0.61, 15.37) | 0.143 |
| NM-Yaquis*OB | −17.40 | 80.06 | −0.02 | 0.02 (0.01, 6.77) | 0.999 |
| High LDL | |||||
| Intercept | −1.78 | 0.46 | −3.84 | 0.17 (0.07, 0.41) | ˂0.001 |
| Age | 0.09 | 0.05 | 1.91 | 1.10 (1.10, 1.20) | 0.062 |
| Gender (Girls) | −0.45 | 0.22 | −2.05 | 0.64 (0.41, 0.97) | 0.042 |
| NM | −0.61 | 0.28 | −2.17 | 0.54 (0.31, 0.93) | 0.033 |
| CM-Puebla | −1.37 | 0.26 | −5.31 | 0.25 (0.15, 0.41) | ˂0.001 |
| Seris | −2.33 | 0.73 | −3.18 | 0.10 (0.02, 0.32) | 0.001 |
| Yaquis | −2.35 | 0.52 | −4.48 | 0.10 (0.03, 0.24) | ˂0.001 |
| Low ApoA1 | |||||
| Intercept | −2.84 | 0.28 | −10.02 | 0.06 (0.03, 0.1) | ˂0.001 |
| OB | 0.94 | 0.42 | 2.26 | 2.57 (1.10, 5.77) | 0.022 |
| Gender (Girls) | 0.92 | 0.33 | 2.82 | 2.51 (1.33, 4.8) | ˂0.001 |
| NM | −1.98 | 0.75 | −2.64 | 0.14 (0.02, 0.48) | 0.011 |
| Seris | −0.3 | 0.53 | −0.57 | 0.74 (0.23, 1.94) | 0.572 |
| Yaquis | 0.9 | 0.33 | 2.76 | 2.47 (1.3, 4.71) | 0.012 |
| Girls*OB | −2.78 | 1.12 | −2.49 | 0.06 (0.03, 0.39) | 0.011 |
| High ApoB | |||||
| Intercept | −1.59 | 0.4 | −3.99 | 0.20 (0.09, 0.44) | ˂0.001 |
| Age | 0.09 | 0.04 | 2.21 | 1.10 (1.01, 1.19) | 0.032 |
| OB | 0.68 | 0.2 | 3.33 | 1.97 (1.32, 2.94) | ˂0.001 |
| NM | 1.22 | 0.21 | 5.72 | 3.38 (2.24, 5.15) | ˂0.001 |
| Seris | −1.23 | 0.38 | −3.23 | 0.29 (0.13, 0.59) | ˂0.001 |
| Yaquis | −0.92 | 0.27 | −3.46 | 0.40 (0.23, 0.66) | ˂0.001 |
| Dyslipidemia | |||||
| Intercept | 1.08 | 0.15 | 7.14 | 2.93 (2.20, 3.97) | ˂0.001 |
| OB | 0.93 | 0.35 | 2.63 | 2.54 (1.31, 5.34) | 0.009 |
| NM | 0.18 | 0.27 | 0.67 | 1.20 (0.71, 2.07) | 0.500 |
| CM-Puebla | −0.86 | 0.19 | −4.45 | 0.42 (0.29, 0.62) | ˂0.001 |
| Seris | −1.41 | 0.3 | −4.67 | 0.24 (0.13, 0.44) | ˂0.001 |
| Yaquis | −1.11 | 0.23 | −4.73 | 0.33 (0.21, 0.52) | ˂0.001 |
| NM-Urban*OB | −1.28 | 0.56 | −2.26 | 0.28 (0.09, 0.85) | 0.022 |
| CM-Puebla*OB | 1.74 | 1.09 | 1.59 | 5.68 (0.96, 10.05) | 0.112 |
| Seris*OB | 1.2 | 1.17 | 1.02 | 3.30 (0.45, 8.29) | 0.314 |
| Yaquis*OB | 0.6 | 0.88 | 0.69 | 1.83 (0.37, 13.59) | 0.492 |
Lipid disorders (high or low levels) were classified according to the borderline-high criteria of the Expert Panel on Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents of the National Heart, Lung and Blood Institute. * interaction, na, information for ApoA1 and ApoB in CM-Puebla is not available.
Figure 1Effect of obesity and the ethnic groups on the probability of lipid disorders in northern and central Mexican child Obesity, 1 = obesity in blue, 0 = normal weight in red (A) high TG (Triglycerides), (B) high TC (total cholesterol), (C) low HDL (high density lipoprotein cholesterol), (D) low ApoA1 (apolipoprotein A1), (E) high ApoB (apolipoprotein B), (F) dyslipidemia. All lipids were measured in mg/dL.